
Misconception: patents held by biopharma companies would lead to limited access to new #medicines and high prices. Read how it really works: NL pharma.be/nl/media/nieuws/be… FR pharma.be/fr/medias/actualit… @debackerphil #Innovation #IP #patents #Research #Belgium



















